FBDD

(redirected from Fragment Based Drug Discovery)
AcronymDefinition
FBDDFragment Based Drug Discovery
FBDDFragment Based Drug Design
FBDDFree Binary Decision Diagram
FBDDFree Binary Decision Diagrams
References in periodicals archive ?
Analyse the potential of emerging technologies for improving the quality of drug candidates and understand how such innovations can improve the ability of fragment based drug discovery and virtual screening to identify new lead compounds.
Chapter 2 Identifying hits: library design, virtual screening and fragment based drug discovery
This problem can be addressed by fragment based drug discovery (FBDD), which uses as starting points very small, low molecular weight, drug fragments.
Heidelberg, Germany based Graffinity Pharmaceuticals is a leader in the field of fragment based drug discovery.
Graffinity will apply its proprietary fragment based drug discovery technology and drug fragment chemical microarrays to identify small molecule hit structures focusing on compounds with novel modes of action.
We believe that this collaboration is a validation of Graffinity's approach of accelerating drug discovery through innovations in fragment based drug discovery.
Graffinity will apply its proprietary fragment based drug discovery technology and drug fragment chemical microarrays to identify and evolve small molecule hit structures focusing on compounds with novel modes of action.